BIOMAT Database Logo BIOMAT Database Logo

[Elective inducing of labor with protaglandin E2 tablets]. 1974

M Thiery, and D de Hemptinne, and A Yo Le Sian, and R Derom, and G Martens, and H Van Kets, and J J Amy

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007751 Labor, Induced Artificially induced UTERINE CONTRACTION. Induced Labor,Induction of Labor,Labor Induced,Labor Induction,Induced, Labor,Induction, Labor,Inductions, Labor,Labor Inductions
D010121 Oxytocin A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION. Ocytocin,Pitocin,Syntocinon
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D011460 Prostaglandins F (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. PGF
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females

Related Publications

M Thiery, and D de Hemptinne, and A Yo Le Sian, and R Derom, and G Martens, and H Van Kets, and J J Amy
Inducing labor with oral prostaglandin E2 tablets.
January 1978, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
M Thiery, and D de Hemptinne, and A Yo Le Sian, and R Derom, and G Martens, and H Van Kets, and J J Amy
[Labor induction with prostaglandin E2 tablets].
January 1978, Gynakologische Rundschau,
M Thiery, and D de Hemptinne, and A Yo Le Sian, and R Derom, and G Martens, and H Van Kets, and J J Amy
Induction of labor in patients with missed abortion and fetal death in utero with protaglandin E2 suppositories.
March 1977, American journal of obstetrics and gynecology,
M Thiery, and D de Hemptinne, and A Yo Le Sian, and R Derom, and G Martens, and H Van Kets, and J J Amy
Inducing labor with oral prostaglandin E2 in Khartoum hospital.
January 1978, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
M Thiery, and D de Hemptinne, and A Yo Le Sian, and R Derom, and G Martens, and H Van Kets, and J J Amy
[Sensitivity test in labor induction with prostaglandin E2 vaginal tablets].
January 1988, Zentralblatt fur Gynakologie,
M Thiery, and D de Hemptinne, and A Yo Le Sian, and R Derom, and G Martens, and H Van Kets, and J J Amy
Intracervical application of prostaglandin E2 tablets for elective induction of labor in grand multiparae: a prospective controlled study.
June 1986, European journal of obstetrics, gynecology, and reproductive biology,
M Thiery, and D de Hemptinne, and A Yo Le Sian, and R Derom, and G Martens, and H Van Kets, and J J Amy
[Labor induction by intravaginal administration of prostaglandin E2 tablets].
February 1987, Geburtshilfe und Frauenheilkunde,
M Thiery, and D de Hemptinne, and A Yo Le Sian, and R Derom, and G Martens, and H Van Kets, and J J Amy
Guidelines for the elective induction of labor with oral Prostaglandin E2.
January 1977, Obstetrics and gynecology,
M Thiery, and D de Hemptinne, and A Yo Le Sian, and R Derom, and G Martens, and H Van Kets, and J J Amy
Induction of labor with oral prostaglandin E2 tablets in high-parity patients.
June 1983, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
M Thiery, and D de Hemptinne, and A Yo Le Sian, and R Derom, and G Martens, and H Van Kets, and J J Amy
[Induced labor using intravaginal administration of tablets containing prostaglandin E2].
January 1984, Gynakologische Rundschau,
Copied contents to your clipboard!